ICD Code | Description |
---|---|
C8100 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
C8101 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck |
C8102 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes |
C8103 | Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes |
C8104 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb |
C8105 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C8106 | Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes |
C8107 | Nodular lymphocyte predominant Hodgkin lymphoma, spleen |
C8108 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites |
C8109 | Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C8100 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C8100 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site | 6.63 | 30.95 | ||||||||||||||||
C8108 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites | 5.61 | 31.71 | ||||||||||||||||
C8103 | Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes | 5.32 | 47.22 | ||||||||||||||||
C8101 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck | 7.87 | 39.29 | ||||||||||||||||
C8104 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb | 6.07 | NA | ||||||||||||||||
C8102 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes | 4.5 | 65.0 | ||||||||||||||||
C8109 | Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites | 6.95 | NA |